What's New at DiaPharma?
Posted: March 3, 2021
It’s Not Just Support. It’s Solutions. Meet the Team Tinu Adewole East Territory Manager Tinu has been with DiaPharma since July 2013. She enjoys staying healthy and active, these days by working with a virtual Personal Trainer, taking walks in the neighborhood, and doing online YouTube pilates & yoga videos. She says, “It took me about 3 months into the pandemic t...Read More
Clot Club #19
Posted: February 16, 2021
INSIGHTS INTO AN IMBALANCED vWF ANTIGEN TO ADAMTS-13 ACTIVITY RATIO IN COVID-19 ...Read More
Insights into an Imbalanced vWF antigen to ADAMTS-13 activity ratio in COVID-19
Posted: February 12, 2021
– Contributed by Abi Kasberg, PhD One of the many complicated outcomes associated with severe cases of COVID-19 is the high occurrence of thrombotic and microthrombotic events. SARS-CoV-2-induced endothelial injury drives elevated inflammatory responses that promote dysregulated coagulation systems, in a condition named COVID-19-associated coagulopathy (CAC). The severity of CAC is as...Read More
PKA Products for Reliable, Convenient IVIG and Albumin Safety Testing
Posted: February 2, 2021
Immunoglobulin Testing Assays Reliable, convenient testing for procoagulant contaminants Diapharma offers a variety of products for sensitive quality control and safety testing to ensure removal of thrombogenic agents in IVIG and Albumin preparations. Prekallikrein Activity Assays Specialty Range of PKA Assay Kits, Reagents & Controls Fractionation of Human plasma to produce Human Alb...Read More
Thank you for Visiting DiaPharma Virtually while attending TLMdX®!
Posted: January 19, 2021
Biomarker Assays for NASH Clinical Trials Thank you for “stopping by” at The Liver Meeting® Digital Experience! Non-invasive biomarkers are becoming more and more prominent in research and clinical trials of potential new drugs for Non-alcoholic fatty liver disease (NAFLD)/Nonalcoholic steatohepatitis (NASH) and Alcoholic Liver Disease (ALD)/Alcoholic Hepatitis (AH). Key changes in ...Read More
Notice of discontinued GSD SARS-CoV-2 IgA ELISA test kits
Posted: January 15, 2021
The Gold Standard Diagnostic SARS-CoV-2 (COVID-19) IgA ELISA assay (#GSD01-1029) has been discontinued and will no longer be available for purchase through DiaPharma. Our current portfolio of COVID-19 serology kits can be found here. ...Read More
Complement Your TMA Research
Posted: January 12, 2021
COUNT ON DIAPHARMA for a Complete Portfolio of Thrombotic Microangiopathy (TMA) Research Products ADAMTS13 Measurement Technozym ADAMTS13 Activity ELISA for determination of ADAMTS13 activity Calibrators & Controls traceable to WHO 1st International Standard ADAMTS13 plasma No interference by bilirubin, hemolytic, or lipemic samples Use for ADAMTS13 inhibitor determination in Bethe...Read More
Thank you for "visiting" us at SETAC SciCon2
Posted: January 12, 2021
Thank You for Visiting DiaPharma at SETAC SciCon2! PERFORM ENDOCRINE DISRUPTOR STUDIES WITHOUT KILLING THE FISH Non-invasive, easy to use, accurate ecotoxicology assays Environmental impact matters. Use TECOmedical Mucus Collection Swabs and ELISA kits to test fish: Follow individuals and populations over time Measure endocrine disruption with our vitellogenin ELISAs Measure liver dam...Read More
Full portfolio of SARS-CoV-2 Antibody ELISAs to suit your needs for stage of immune response, sensitivity needs, and price point.
Posted: January 12, 2021
The quality you trust from DiaPharma Full portfolio of SARS-CoV-2 Antibody ELISAs to suit your needs for stage of immune response, sensitivity needs, and price point. • Ideal for COVID-19 research, epidemiological studies, vaccine development, long-term efficacy or sustainability of immune response • Open-system, standard ELISAs that require no special readers and can be automated for hig...Read More
Don't Miss the Award Winning AACC Poster on the new T-TAS 01 Platelet Function Analyzer!
Posted: December 22, 2020
Poster Alert! AACC Virtual Event’s “2020 Hematology and Coagulation Division’s Best Abstract Award” Jump straight to the good stuff and check out “Comparison of the T-TAS® 01 PL Assay with PFA-100 for Assessment of Primary Hemostatic Function” (B136), presented by Jeffrey Dahlen. Live poster Q&A chat session on Wednesday, December 16 from 12:30 – 1:3...Read More
Complement Your TMA Research
Posted: December 15, 2020
COUNT ON DIAPHARMA for a Complete Portfolio of Thrombotic Microangiopathy (TMA) Research Products ADAMTS13 Measurement Technozym ADAMTS13 Activity ELISA for determination of ADAMTS13 activity Calibrators & Controls traceable to WHO 1st International Standard ADAMTS13 plasma No interference by bilirubin, hemolytic, or lipemic samples Use for ADAMTS13 inhibitor determination in Be...Read More
Large Portfolio of SARS-CoV-2 Antibody ELISAs from DiaPharma
Posted: November 24, 2020
The quality you trust from DiaPharma Full portfolio of SARS-CoV-2 Antibody ELISAs to suit your needs for stage of immune response, sensitivity needs, and price point Ideal for COVID-19 research, epidemiological studies, vaccine development, long-term efficacy or sustainability of immune response Open-system, standard ELISAs that require no special readers and can be automated for higher throughp...Read More
Diapharma Announces Partnership with Proaxsis
Posted: November 18, 2020
ProAxsis Limited (www.proaxsis.com), the Belfast-based diagnostics company specialising in the measurement of active proteases and other inflammatory biomarkers, today announces that it has appointed Diapharma Group Inc. as the exclusive distributor of its portfolio of respiratory research assays for the North America region. Based in Ohio, Diapharma has specialised in the commercialisation of pro...Read More
Collagen IV for Liver Fibrosis Research: Not just a kidney collagen
Posted: November 12, 2020
DiaPharma Serum Collagen IV ELISA Biomarker of Liver Fibrosis Easy To Use ELISA Now Available from DiaPharma Clinical research quality ELISA with an established publication record now available from DiaPharma Simple-to-use, well-characterized mAb sandwich ELISA Non-invasive fibrosis serum biomarker for liver research (NASH, AH, Hepatitis) Diapharma offers an established, well-published Human C...Read More
Visit us Virtually at SETAC SciCon2
Posted: November 12, 2020
Virtual Conference, Real Swag! Get Your Free T-shirt* at the SETAC North America 41st Annual Meeting! PERFORM ENDOCRINE DISRUPTOR STUDIES WITHOUT KILLING THE FISH *While supplies last We look forward to talking with you about our for Non-invasive, easy to use, accurate ecotoxicology assays. Environmental impact matters. Use TECOmedical Mucus Collection Swabs and ELISA kits to test fi...Read More
Visit DiaPharma while attending The Liver Meeting® Digital Experience
Posted: November 11, 2020
Biomarker Assays for NASH Clinical Trials Virtual Conference, Real Swag! Visit us virtually while attending The Liver Meeting® Digital Experience, and get a voucher for a FREE 2020 T-SHIRT! Learn about Mechanistic Liver Biomarkers DiaPharma offers non-invasive biomarker assays for NAFLD/NASH, AH, and DILI research. Gain valuable information, save time and costs, by incorporat...Read More
Unique C1-INH Activity Assay for Gene Therapy Research
Posted: November 9, 2020
Technochrom C1-INH Easy, Automatable Assay for Measuring C1 Esterase Inhibitor (C1-INH) Activity Simple and fast assay for chromogenic determination of C1-INH activity in plasma or concentrates Useful for gene therapy studies in Hereditary Angioedema (HAE) Ref: Qiu T, Chiuchiolo MJ, Whaley AS, et al. Gene therapy for C1 esterase inhibitor deficiency in a Murine Model of Hereditary angioedema. Al...Read More
What's New at Diapharma?
Posted: November 3, 2020
Staff Spotlight Tom Boulden Western Territory Manager Tom Boulden joined the Diapharma team as the Western Territory Manager in February of 2017 fresh out of his military service. Tom’s background includes his experience as a Chemical, Biological, Radiological, and Nuclear NCO in the Army, and a MS degree in Biomedical Diagnostics from Arizona State University. While Tom enjoyed laboratory work...Read More
M65 EpiRat™ ELISA - Assess liver safety signals in drug development
Posted: October 22, 2020
M65 EpiRat™ ELISA New Tool for Preclinical Drug Safety Studies Why Use the M65 EpiRat™ ELISA? Increased sensitivity and liver specificity compared to traditional biomarkers (ALT, AST) – complementary biomarker for your DILI toolbox Detect liver toxicity signals at an early stage in drug development by directly measuring hepatocyte cell death caused by the drug ...Read More